Biocept, Inc.
(NASDAQ : BIOC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.41%201.631.2%$403.74m
GILDGilead Sciences, Inc.
-0.22%72.620.9%$393.60m
CELGCelgene Corporation
0.24%87.411.2%$339.95m
BIIBBiogen Inc.
0.27%335.311.2%$274.71m
ILMNIllumina, Inc.
1.53%352.543.5%$256.11m
REGNRegeneron Pharmaceuticals, Inc.
-1.32%381.402.6%$207.47m
EXASExact Sciences Corporation
-0.61%72.8825.3%$197.46m
VRTXVertex Pharmaceuticals Incorporated
0.33%176.381.9%$160.40m
SRPTSarepta Therapeutics, Inc.
0.43%153.0116.4%$125.41m
AAgilent Technologies, Inc.
-0.72%68.581.5%$120.61m
ALXNAlexion Pharmaceuticals, Inc.
1.17%119.182.0%$108.75m
NKTRNektar Therapeutics
0.58%58.655.6%$96.52m
ALNYAlnylam Pharmaceuticals, Inc
-0.10%93.269.7%$95.72m
BMRNBioMarin Pharmaceutical Inc.
0.72%98.864.4%$91.34m
INCYIncyte Corporation
0.67%67.472.5%$88.30m

Company Profile

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.